Rigorous and rapid evidence assessment in digital health with the evidence DEFINED framework
[ad_1]
IQVIA. Digital health trends 2021: innovation, evidence, regulation, and adoption. https://www.iqvia.com/insights/the-iqvia-institute/reports/digital-health-trends-2021 (2021).
Guo, C. et al. Challenges for the evaluation of digital health solutions—a call for innovative evidence generation approaches. NPJ Digital Med. 3, 1–14 (2020).
American Medical Association. AMA unveils playbook to speed digital health adoption. https://www.ama-assn.org/practice-management/digital/ama-unveils-playbook-speed-digital-health-adoption (2018).
American Psychiatric Association. The App Evaluation Model. https://www.psychiatry.org/psychiatrists/practice/mental-health-apps/the-app-evaluation-model (2021).
Stanford University Center for Digital Health & Rock Health. Digital Health Consumer Adoption Report 2020. https://rockhealth.com/reports/digital-health-consumer-adoption-report-2020/ (2020).
Ginsburg, G. Digital health—the need to assess benefits, risks, and value on apple podcasts. JAMA Author Interviews https://podcasts.apple.com/gh/podcast/digital-health-the-need-to-assess-benefits-risks-and-value/id410339697?i=1000503812426 (2021).
Mathews, S. C. et al. Digital health: a path to validation. NPJ Digit Med. 2, 38 (2019).
Sedhom, R., McShea, M. J., Cohen, A. B., Webster, J. A. & Mathews, S. C. Mobile app validation: a digital health scorecard approach. npj Digit. Med. 4, 1–8 (2021).
Wisniewski, H. et al. Understanding the quality, effectiveness and attributes of top-rated smartphone health apps. Evid. Based Ment. Health 22, 4–9 (2019).
Perakslis, E. & Ginsburg, G. S. Digital health-The need to assess benefits, risks, and value. JAMA https://doi.org/10.1001/jama.2020.22919 (2020).
Bruce, C. et al. Evaluating patient-centered mobile health technologies: definitions, methodologies, and outcomes. JMIR mHealth uHealth 8, e17577 (2020).
Fleming, G. A. et al. Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD and the American Diabetes Association (ADA) Diabetes Technology Working Group. Diabetologia 63, 229–241 (2020).
Lagan, S. et al. Actionable health app evaluation: translating expert frameworks into objective metrics. NPJ Digit. Med. 3, 100 (2020).
Gupta, K., Frosch, D. L. & Kaplan, R. M. Opening the black box of digital health care: making sense of “evidence”. Health Affairs Forefront (2021).
Goldsack, J. et al. Digital health, digital medicine, digital therapeutics (DTx): what’s the difference? https://www.dimesociety.org/digital-health-digital-medicine-digital-therapeutics-dtx-whats-the-difference/ (2019).
U.S. Food & Drug Administration. FDA launches the Digital Health Center of Excellence. https://www.fda.gov/news-events/press-announcements/fda-launches-digital-health-center-excellence (2020).
Food and Drug Administration. Digital Health Center of Excellence. https://www.fda.gov/medical-devices/digital-health-center-excellence (2022).
Guyatt, G. H. et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336, 924–926 (2008).
Parekh, A. K., Goodman, R. A., Gordon, C. & Koh, H. K., HHS Interagency Workgroup on Multiple Chronic Conditions. Managing multiple chronic conditions: a strategic framework for improving health outcomes and quality of life. Public Health Rep. 126, 460–471 (2011).
Proudman, D., Greenberg, P. & Nellesen, D. The growing burden of major depressive disorders (MDD): implications for researchers and policy makers. Pharmacoeconomics 39, 619–625 (2021).
Centers for Disease Control and Prevention. Health and economic costs of chronic diseases | CDC. https://www.cdc.gov/chronicdisease/about/costs/index.htm (2022).
Anderson, G. & Horvath, J. The growing burden of chronic disease in America. Public Health Rep. 119, 263–270 (2004).
Schueller, S. M. Grand challenges in human factors and digital health. Front. Digit. Health 3, 635112 (2021).
Hensher, M. et al. Scoping review: Development and assessment of evaluation frameworks of mobile health apps for recommendations to consumers. J. Am. Med Inf. Assoc. 28, 1318–1329 (2021).
Moshi, M. R., Tooher, R. & Merlin, T. Suitability of current evaluation frameworks for use in the health technology assessment of mobile medical applications: a systematic review. Int. J. Technol. Assess. Health Care 34, 464–475 (2018).
Kowatsch, T., Otto, L., Harperink, S., Cotti, A. & Schlieter, H. A design and evaluation framework for digital health interventions. It – Inf. Technol. 61, 253–263 (2019).
Lagan, S., Sandler, L. & Torous, J. Evaluating evaluation frameworks: a scoping review of frameworks for assessing health apps. BMJ Open 11, e047001 (2021).
Parcher, B. & Coder, M. Decision makers need an approach to determine digital therapeutic product quality, access, and appropriate use. JMCP 27, 536–538 (2021).
Baumel, A., Faber, K., Mathur, N., Kane, J. M. & Muench, F. Enlight: a comprehensive quality and therapeutic potential evaluation tool for mobile and web-based eHealth interventions. J. Med. Internet Res. 19, e7270 (2017).
Leigh, S., Ouyang, J. & Mimnagh, C. Effective? Engaging? Secure? Applying the ORCHA-24 framework to evaluate apps for chronic insomnia disorder. Evid.-Based Ment. Health 20, e20 (2017).
Wyatt, J. C. et al. What makes a good clinical app? Introducing the RCP Health Informatics Unit checklist. Clin. Med. 15, 519–521 (2015).
IQVIA. AppScript | discover, deliver & track digital health. https://www.appscript.net/score-details (2021).
Silberman, J., Sarlati, S., Kaur, M. & Bokhari, W. Chapter 23–Outcomes assessment for digital health interventions in diabetes: a payer perspective. in Diabetes Digital Health and Telehealth (eds. Klonoff, D. C., Kerr, D. & Weitzman, E. R.) 291–304 (Academic Press, 2022). https://doi.org/10.1016/B978-0-323-90557-2.00023-6.
Mayo-Wilson, E. et al. Clinical trial registration and reporting: a survey of academic organizations in the United States. BMC Med. 16, 60 (2018).
Chen, C. E., Harrington, R. A., Desai, S. A., Mahaffey, K. W. & Turakhia, M. P. Characteristics of digital health studies registered in ClinicalTrials.gov. JAMA Intern. Med. 179, 838–840 (2019).
National Institutes of Health. Summary table of HHS/NIH initiatives to enhance availability of clinical trial Information. https://www.nih.gov/news-events/summary-table-hhs-nih-initiatives-enhance-availability-clinical-trial-information (2016).
Manta, C. et al. EVIDENCE publication checklist for studies evaluating connected sensor technologies: explanation and elaboration. Digit Biomark. 5, 127–147 (2021).
American Medical Association. Return on health: moving beyond dollars and cents in realizing the value of virtual care. https://www.ama-assn.org/system/files/2021-05/ama-return-on-health-report-may-2021.pdf (2021).
Klonoff, D. C. & Price, W. N. The need for a privacy standard for medical devices that transmit protected health information used in the precision medicine initiative for diabetes and other diseases. J. Diabetes Sci. Technol. 11, 220–223 (2017).
World Economic Forum. Shared guiding principles for digital health inclusion. https://www.weforum.org/reports/shared-guiding-principles-for-digital-health-inclusion/ (2021).
Siemieniuk, R & Guyatt, G. What is GRADE? https://bestpractice.bmj.com/info/us/toolkit/learn-ebm/what-is-grade/ (2020).
Stoyanov, S. R. et al. Mobile App Rating Scale: a new tool for assessing the quality of health mobile apps. JMIR mHealth uHealth 3, e3422 (2015).
O’Rourke, T., Pryss, R., Schlee, W. & Probst, T. Development of a multidimensional app-quality assessment tool for health-related apps (AQUA). Digit Psych. 1, 13–23 (2020).
Cagan, M & Jones, C. EMPOWERED: Ordinary People, Extraordinary Products | Wiley. (Wiley, 2021).
Digital Medicine Society. About us. https://www.dimesociety.org/about-us/ (2022).
Espie, C. A., Torous, J. & Brennan, T. A. Digital therapeutics should be regulated With gold-standard evidence. Health Affairs Forefront https://doi.org/10.1377/forefront.20220223.739329 (2022).
Tricco, A. C. et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann. Intern. Med. 169, 467–473 (2018).
Grant, M. J. & Booth, A. A typology of reviews: an analysis of 14 review types and associated methodologies. Health Info. Libr. J. 26, 91–108 (2009).
Nouri, R., R Niakan Kalhori, S., Ghazisaeedi, M., Marchand, G. & Yasini, M. Criteria for assessing the quality of mHealth apps: a systematic review. J. Am. Med. Inf. Assoc. 25, 1089–1098 (2018).
National Collaborating Centre for Methods and Tools. Grey matters: a practical tool for searching health-related grey literature. https://www.nccmt.ca/knowledge-repositories/search/130 (2019).
[ad_2]
Source link
